Article info

Download PDFPDF
In stable COPD, long-acting muscarinic antagonist plus long-acting beta-agonists resulted in less exacerbations, pneumonia and larger improvement in FEV 1 than long-acting beta-agonists plus inhaled corticosteroids

Authors

  1. Correspondence to Professor Mario Cazzola, Department of Systems Medicine, University Rome Tor Vergata, Via Montpellier 1, Rome 00133, Italy; mario.cazzola{at}uniroma2.it
View Full Text

Citation

Cazzola M, Rogliani P
In stable COPD, long-acting muscarinic antagonist plus long-acting beta-agonists resulted in less exacerbations, pneumonia and larger improvement in FEV 1 than long-acting beta-agonists plus inhaled corticosteroids

Publication history

  • First published August 11, 2017.
Online issue publication 
October 04, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.